CAS proteins in health and disease: An update

Anna S. Nikonova, Anna V. Gaponova, Alexander E. Kudinov, Erica A. Golemis

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations

Abstract

The CAS family of scaffolding proteins has increasingly attracted scrutiny as important for regulation of cancer-associated signaling. BCAR1 (also known as p130Cas), NEDD9 (HEF1, Cas-L), EFS (Sin), and CASS4 (HEPL) are regulated by and mediate cell attachment, growth factor, and chemokine signaling. Altered expression and activity of CAS proteins are now known to promote metastasis and drug resistance in cancer, influence normal development, and contribute to the pathogenesis of heart and pulmonary disease. In this article, we provide an update on recently published studies describing signals regulating and regulated by CAS proteins, and evidence for biological activity of CAS proteins in normal development, cancer, and other pathological conditions.

Original languageEnglish
Pages (from-to)387-395
Number of pages9
JournalIUBMB Life
Volume66
Issue number6
DOIs
StatePublished - Jun 2014

Keywords

  • human molecular disease
  • protein function
  • signal transduction

Fingerprint

Dive into the research topics of 'CAS proteins in health and disease: An update'. Together they form a unique fingerprint.

Cite this